|
|
||||||||
1 Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, and 2 Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294
Pathophysiological features of both primary aldosteronism and pseudohyperaldosteronism are hyperactive amiloride-sensitive epithelial Na+ channels (ENaC) and refractory hypertension. Peripheral blood lymphocytes express ENaC, which functions and is regulated similarly to ENaC expressed by renal principal cells. Thus it was hypothesized that individuals with either of these hypertensive etiologies could be identified by assessment of the function and regulation of peripheral blood lymphocyte ENaC, by whole cell patch clamp. We also tested the hypothesis that specific inhibition of hyperactive ENaC with amiloride could ameliorate the hypertension. To test these hypotheses, we solicited blood samples from normotensive, controlled hypertensive, and refractory hypertensive individuals. Lymphocytes were examined electrophysiologically to determine whether ENaC was hyperactive. All positive findings were from refractory hypertensive individuals. Nine refractory hypertensive patients had amiloride added to their hypertensive therapy. Amiloride normalized the blood pressure of four subjects. These individuals all had hyperactive ENaC. Amiloride had no effect on individuals with normal ENaC. These findings suggest that whole-cell patch clamp of peripheral blood lymphocytes can be used to identify accurately and rapidly hypertensive individuals who will respond to amiloride therapy.
sodium channel; lymphocytes; aldosterone
This article has been cited by other articles:
![]() |
S. Oparil, M. A. Zaman, and D. A. Calhoun Pathogenesis of Hypertension Ann Intern Med, November 4, 2003; 139(9): 761 - 776. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The Promise of Translational Physiology J Neurophysiol, February 1, 2003; 89(2): 646 - 647. [Full Text] [PDF] |
||||
![]() |
Z.-H. Zhou and J. K. Bubien ENaC plays a role in regulated antibody secretion by hybridomas Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1480 - C1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E193 - E194. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L235 - L236. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Renal Physiol, August 1, 2002; 283(2): F207 - F208. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1259 - R1260. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H803 - H804. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology J Appl Physiol, February 1, 2002; 92(2): 425 - 426. [Full Text] [PDF] |
||||
![]() |
J. E. Hall The promise of translational physiology Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1411 - C1412. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |